Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 11, 2005, Pages 903-911

  Margolin, Kim A ^a   Doroshow, James H ^a   Frankel, Paul ^a   Chow, Warren ^a   Leong, Lucille A ^a   Lim, Dean ^a   McNamara, Mark ^a   Morgan, Robert J ^a   Shibata, Stephen ^a   Somlo, George ^a   Twardowski, Przemyslaw ^a   Yen, Yun ^a   Kogut, Neil ^a   Schriber, Jeffrey ^a   Alvarnas, Joseph ^a   Stalter, Susan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Autologous peripheral stem cell support; Germ cell tumors; High dose chemotherapy; Paclitaxel

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMPHOTERICIN; CARBOPLATIN; CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; IFOSFAMIDE; LEVOFLOXACIN; LORAZEPAM; MESNA; PACLITAXEL;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; GERM CELL TUMOR; HERPES SIMPLEX; HUMAN; LIVER TOXICITY; MALE; MORTALITY; MYCOSIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PREDICTION; PROBABILITY; PROGNOSIS; REMISSION; STEM CELL MOBILIZATION; STOMATITIS; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PACLITAXEL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 27844528490     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.07.010     Document Type: Article

References (21)

1. L.H. Einhorn Treatment of testicular cancer: A new and improved model J Clin Oncol 8 1990 1777-1781
2. R.J. Motzer G.J. Bosl High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions [review] J Natl Cancer Inst 84 1992 1703-1709
3. K.A. Margolin High-dose chemotherapy and stem cell support in the treatment of germ cell cancer [review] J Urol 169 2003 1229-1233
4. International Germ Cell Cancer Collaborative Group International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers J Clin Oncol 15 1997 594-603
5. R.J. Motzer D.F. Bajorin L.H. Schwartz et al. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors J Clin Oncol 12 1994 2277-2283
6. S.M. Stemmer P.J. Cagnoni E.J. Shpall et al. High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: A phase I trial J Clin Oncol 14 1996 1463-1473
7. G. Somlo J.H. Doroshow T. Synold et al. High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: Toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome Br J Cancer 84 2001 1591-1598
8. L.A. Leong J. Raschko G. Somlo et al. Phase I tandem cycle high-dose chemotherapy with cisplatin, etoposide, and cyclophosphamide followed by ifosfamide, carboplatin, escalating doses of paclitaxel and stem cell rescue [abstract 479] Proc Am Soc Clin Oncol 20 2001 121a
9. K.A. Margolin J.H. Doroshow C. Ahn et al. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support J Clin Oncol 14 1996 2631-2637
10. C. Iniguez P. Larrode J.I. Mayordomo et al. Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel Neurology 51 1998 868-870
11. A. Calvert D. Newell L. Gumbrell et al. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function J Clin Oncol 7 1989 1748-1756
12. + selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer Blood 89 1997 1521-1528
13. J. Beyer A. Kramar R. Mandanas et al. High-dose chemotherapy as salvage treatment in germ cell tumors a multivariate analysis of prognostic variables J Clin Oncol 14 1996 2638-2645
14. D. Raghavan Testicular cancer maintaining the high cure rate Oncology 17 2003 218-230
15. G.C. Toner N.L. Geller C. Tan et al. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors Cancer Res 50 1990 5904-5910
16. M. Mazumdar D.F. Bajorin J. Bacik et al. Predicting outcome to chemotherapy in patients with germ cell tumors: The value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy J Clin Oncol 19 2001 2534-2541
17. R.J. Motzer M. Mazumdar S.C. Gulati et al. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors J Natl Cancer Inst 85 1993 1828-1835
18. R.J. Motzer M. Mazumdar D.F. Bajorin et al. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors J Clin Oncol 15 1997 2546-2552
19. R.J. Motzer M. Mazumdar J. Sheinfeld et al. Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients J Clin Oncol 18 2000 1173-1180
20. G.V. Kondagunta J. Bacik D.F. Bajorin et al. Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts) [abstract] Proc Am Soc Clin Oncol 23 2005 378
21. J.L. Pico G. Rosti A. Kramar et al. A randomized trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors Ann Oncol 16 2005 1152-1159